New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
14:25 EDTVRTX, VRTX, VRTXLeerink pharma and biotech analysts hold an analyst/industry conference call
Biotech/Pharmaceuticals Analysts, along with Key Opinion Leaders (KOL) discuss, head of the data release, Vertex's Phase 3 TRAFFIC and TRANSPORT Phase 3 Studies on an Analyst/Industry conference call to be held on May 8 at 3 pm.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
07:45 EDTVRTXVertex initiated with a Buy at Canaccord
Target $150.
April 9, 2015
10:48 EDTVRTXDeutsche compares PTC Therapeutics to Vertex, boosts target by $40
Subscribe for More Information
07:27 EDTVRTXPTC Therapeutics price target raised to $115 from $75 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use